European partnership fostering a European Research Area (ERA) for health research
The European Partnership fostering a European Research Area (ERA) for health research aims to create a cohesive and effective health research landscape across Europe. This collaborative initiative will unite diverse funding bodies and research entities to jointly program and fund health-related research and innovation, specifically targeting major disease burdens and healthcare system challenges.
Who is Funded by the ERA Health Partnership
This partnership seeks to fund a broad spectrum of entities committed to advancing health research across Europe. It targets public and philanthropic funders, research institutions, and health authorities within EU Member States, countries associated with Horizon Europe, and encourages participation from third countries. The overarching goal is to collaboratively address global health challenges and strengthen healthcare systems.
What is Funded by the ERA Health Partnership
The ERA Health Partnership funds a wide array of research and innovation activities focused on understanding, preventing, diagnosing, and treating diseases. This includes support for clinical studies and covers various developmental stages from fundamental research to market introduction, with a focus on specific health challenges and the development of innovative health technologies.
Type and Scope of Funding for Health Research
The ERA Health Partnership offers substantial grant funding, with a total EU contribution of EUR 110 million over seven years. It operates through joint calls for proposals, enabling financial support to be cascaded to third parties for specific research and innovation activities.
Conditions and Requirements for ERA Health Research Funding
Applicants to the ERA Health Partnership must adhere to detailed conditions regarding proposal submission, consortium formation, budget management, and broader regulatory and ethical guidelines. These provisions ensure high standards of research and responsible innovation.
Application Procedure for ERA Health Funding
The application process for the ERA Health Partnership operates through a single-stage submission via the Funding & Tenders Portal. Proposals are rigorously evaluated based on predefined criteria, with support available through comprehensive guidance documents and helpdesks.
Legal Basis of the ERA Health Partnership
The ERA Health Partnership is firmly rooted in the legal framework of Horizon Europe, the EU's primary research and innovation program. Its operation is guided by a series of detailed regulations and policies, ensuring transparency and compliance with European Union objectives.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
10,000,000 EUR
Allocated Budget:
110,000,000 EUR
Open Until:
31.12.2027
Award Channel:
Framework Programme Call
Region:
EU Member States, countries associated to Horizon Europe, Other (third countries)
Sectors:
Healthcare, Medical Technology, Research and Development, Information and Communication Technology, Pharmaceutical Industry, Food Processing
Application Type:
Consortium Required
Funding Stages:
Basic Research, Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Process Optimization, Market Introduction, Commercialization, Planning, Policy Development, Implementation, Capacity Building
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Additional Partners:
Other Horizon Europe partnerships and missions, EU4Health Programme, Digital Europe Programme (DIGITAL), European Social Fund Plus (ESF+), European Regional Development Fund (ERDF), InvestEU, Recovery and Resilience Facility (RRF), Technical Support Instrument (TSI), European Clinical Research Infrastructure Network (ECRIN), Biobanking and Biomolecular Resources Research Infrastructure (BBMRI)
Website: